Nuvation Bio’s $250M funding; Leqembi rejected again in Australia
Plus, news about IN8bio and Syros: Nuvation Bio’s new funding: The New York biotech will get $150 million in royalty interest financing and up to $100 million ...

Apr 18, 2025 0
Apr 18, 2025 0
Apr 17, 2025 0
Apr 17, 2025 0
Apr 17, 2025 0
Apr 17, 2025 0
Or register with email
Feb 13, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 19, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.